US FDA warns about Medline beds after 2 deaths and 16 serious injuries

Medline removes and corrects all brand beds and accessories

Published October 29, 2026
US FDA warns about Medline beds after 2 deaths and 16 serious injuries
US FDA warns about Medline beds after 2 deaths and 16 serious injuries

The US Food and Drug Administration on Thursday issued a warning about safety risks linked to Medline beds and accessories following the company’s report of two deaths and 16 serious injuries linked to safety risks, fire hazards and life-threatening entrapment dangers.

In accordance with the regulator, Medline has told customers it is exiting the market for all Medline-branded beds and associated products, such as home care heavy-duty hospital beds along with accessories and replacement parts.

The FDA further clarified Medline detected a potential thermal combustion risk within the electric profiling beds’ power systems and handset peripherals. On October 20, the company received reports of two deaths and 16 severe complications linked with the issues. 

 The FDA said electrical components are prone to thermal instability under specific parameters potentially causing smoking, melting and burning or fires. The company said affected beds could continue to be used under revised guidance, and provided users with revised safety instructions. 

In addition, the revised safety protocols mandate disconnecting the bed from the power source when not actively adjusting positioning and extension cables are not permitted under any circumstances.

Ruqia Shahid
Ruqia Shahid is a reporter specialising in science, focusing on discoveries, research developments, and technological advancements. She translates complex scientific concepts into clear, engaging stories, helping readers understand the latest innovations and their real-world impact through accurate, accessible, and insight-driven reporting.